STOCK COMMENTS / EPS CHANGESGilead ( GILD) estimates, target increased at Jefferies. GILD estimates were raised through 2013, Jefferies said. Stribild quad pill was approved with the FDA and the company announced higher pricing. Hold rating and new $55 price target. Ingersoll-Rand ( IR) target raised at UBS to $54, UBS said. Several potential catalysts including improving HVAC business conditions. Buy rating. M&T Bank ( MTB - Get Report) numbers boosted at Credit Suisse. Shares of MTB now seen reaching $102, according to Credit Suisse. Estimates also upped, as the HCBK acquisition should add to earnings. Neutral rating. PVH ( PVH) estimates, target raised at Brean. Shares of PVH now seen reaching $115, according to Brean Murray. Estimates also increased, as the company is seeing better growth across the board. Buy rating. Rackspace ( RAX) target boosted at JMP. Shares of RAX now seen reaching $65, according to JMP Securities. Company can continue to grow through its potential inclusion in the OpenStack Foundation. Outperform rating. VMWare ( VMW - Get Report) target raised at ThinkEquity to $105. Company can create a true enterprise datacenter destination. Buy rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.